Nivolumab (nivo) in combination with radiotherapy (RT) +/- temozolomide (TMZ): Updated safety results from CheckMate 143 in pts with methylated or unmethylated newly diagnosed glioblastoma (GBM) Meeting Abstract
| Authors: | Lim, M.; Omuro, A.; Vlahovic, G.; Reardon, D. A.; Sahebjam, S.; Cloughesy, T.; Baehring, J.; Butowski, N.; Potter, V.; Zwirtes, R.; Paliwal, P.; Carleton, M.; Sampson, J.; Brandes, A. A. |
| Abstract Title: | Nivolumab (nivo) in combination with radiotherapy (RT) +/- temozolomide (TMZ): Updated safety results from CheckMate 143 in pts with methylated or unmethylated newly diagnosed glioblastoma (GBM) |
| Meeting Title: | 42nd ESMO Congress (ESMO 2017) |
| Journal Title: | Annals of Oncology |
| Volume: | 28 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2017 Sep 8-12 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-09-01 |
| Start Page: | mdx366 |
| Language: | English |
| ACCESSION: | WOS:000411324001027 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdx366 |
| Notes: | Meeting Abstract: 325O -- Source: Wos |
